Alexander Nicoll

Recent Articles By The Author

International Flavors & Fragrances Plummets After Poor Fourth Quarter

International Flavors & Fragrances Plummets After Poor Fourth Quarter

The company misses earnings and revenue estimates for the fourth quarter.

Wolverine World Wide Rises After Share Buyback Announcement

Wolverine World Wide Rises After Share Buyback Announcement

The apparel and footwear manufacturer raised its quarterly dividend and restructured its capital improvement plan.

AmerisourceBergen Jumps on Revenue, EPS Beats in Q1

AmerisourceBergen Jumps on Revenue, EPS Beats in Q1

AmerisourceBergen's distribution services drove growth, but the company still narrowed its EPS guidance for the rest of 2019.

Brinker Stock Falls Despite Higher EPS and Net Income in Q2

Brinker Stock Falls Despite Higher EPS and Net Income in Q2

The restaurant chain operator's second-quarter results have not convinced investors of its growth.

New EIA Report Predicts U.S. Energy Independent by 2020

New EIA Report Predicts U.S. Energy Independent by 2020

The U.S. agency expects oil production to top 14 million barrels a day by 2040.

United Rentals Soars More Than 6% on Strong Revenue

United Rentals Soars More Than 6% on Strong Revenue

The rental company is still soaring Thursday after reporting a beat on revenue and adjusted earnings Wednesday.

Zumiez Jumps More Than 7% After Raising Guidance, EPS Forecast

Zumiez Jumps More Than 7% After Raising Guidance, EPS Forecast

The shoe retailer posted strong sales numbers for December. The stock is climbing Thursday.

Google Tags Los Angeles Mall as New Space for Office Campus

Google Tags Los Angeles Mall as New Space for Office Campus

The software giant's lease on the space planned for 14 years.

Mattel Rising on New Planned Barbie Movie

Mattel Rising on New Planned Barbie Movie

The first ever live-action Barbie movie is coming to the big screen.

Why Investors Should Favor Smaller Biotech Companies

Why Investors Should Favor Smaller Biotech Companies

Small and mid-cap biotech firms are driving innovation in the sector. Experts explain why investors should take notice.